Public health officials are tracking an early and perhaps severe influenza season unfolding across Europe and North America, with the emergence of a new H3N2 variant-dubbed subclade K-driving a surge in cases weeks ahead of typical seasonal patterns. The Global Virus Network has issued an alert regarding the rapid spread of this strain, which exhibits characteristics suggesting increased transmissibility and the ability to partially evade existing immunity. While current flu vaccines are expected to offer some protection, this evolving situation underscores the importance of preventative measures, particularly vaccination, as healthcare systems brace for potential strain this winter, following the notably mild flu seasons of 2022 and 2023.
Health officials are warning of an unusually early start to flu season across Europe and North America, with cases appearing three to four weeks sooner than in the past two years. The early surge is prompting calls for swift action, particularly vaccination, to protect against severe illness this winter. This comes as a crucial reminder of the importance of preventative measures against respiratory viruses as we head into the colder months.
New H3N2 Subclade Driving Early Increase
A new strain of influenza A (H3N2), known as subclade K, is believed to be responsible for the accelerated spread. Experts have observed a rise in cases, particularly among children, both in France and across Europe, signaling a potential early onset of the flu epidemic. “There is an increase in viruses, especially among children, both in France and in Europe,” confirmed Anne-Claude Crémieux to Franceinfo. “We know that this is the first sign of the start of the flu epidemic.”
The Global Virus Network (GVN) issued an alert on November 20, noting the rapid spread of the variant and its potential to contribute to a more intense flu season globally. Health agencies in the United Kingdom, several European countries, Japan, and parts of North America have reported significant weekly increases in cases linked to this subclade, indicating an acceleration of its global propagation.
Increased Transmissibility and Immune Evasion
Virologists with the GVN are concerned about the new strain due to its potential for increased transmissibility and partial immune evasion. The H3N2 K subclade is an evolved branch of the seasonal H3N2 viruses that circulate annually and has accumulated mutations that may allow it to spread more easily and partially evade existing immunity. Surveillance data shows particularly rapid growth in the United Kingdom and Western Europe (including France and Germany), with increasing cases also detected in Canada and the Northeastern United States, as well as increased flu activity in East Asia.
While the currently available flu vaccine isn’t a perfect match for the new strain, experts from the GVN emphasize that it still offers protection against severe illness and hospitalization. “These subtle modifications can make it more difficult for the immune system to fully recognize the virus, even in people who have been previously infected or vaccinated,” explained Dr. Peter Palese, a flu virologist and director of the GVN Center of Excellence at the Icahn School of Medicine at Mount Sinai (New York, USA). “Despite this drift, vaccination remains our most effective measure to prevent severe illness and reduce pressure on hospitals.” The findings underscore the continued importance of vaccination even as viruses evolve.
Who is at Risk?
In France, the flu vaccine is fully covered for:
• Individuals aged 65 years and older;
• People under 65 years of age, including children aged 6 months and older, suffering from certain chronic illnesses;
• Pregnant women;
• People with obesity: a body mass index (BMI) of 40 or greater;
• Individuals residing in a rehabilitation facility or a social care facility, regardless of age.
